Findings from a new study showed that people who eat chicken might have increased cancer risk i.e. non-Hodgkin’s lymphoma and lymphatic cancer. Researchers from Oxford University in the UK tracked 475,000 middle-aged Britons between 2016 and 2014 in the latest study published in the Journal of Epidemiology and Community Health.
The researchers analyzed the diets and diseases of the participants. Approximately 23,000 people were later diagnosed with cancer.
Non-Hodgkin Lymphoma
Researchers found a link between chicken consumption and increased risk of non-Hodgkin’s lymphoma, lymphatic cancer, the body’s disease-fighting network.
Tumors arise from a type of white blood cell called lymphocytes in non-Hodgkin’s lymphoma. The disease is characterized by painless yet swollen neck lymph nodes, axes or groin, constant weakness, abdominal pain or swelling, fever, night sweats, unexplained weight loss, chest pain, and breathing problems.
The study also found a correlation between consuming white meat and increasing men’s risk of malignant melanoma and prostate cancer.
Prostate cancer and melanoma
Prostate cancer affects the prostate gland that produces some of the semen fluid and plays a role in men’s urine control. It is the most common cancer in men, although it can be treated if it is detected early.
Melanoma is the most extreme among types of skin cancer. This grows in the melanocytes that create melanin, the pigment that gives color to the body. The condition is commonly associated with exposure to ultraviolet radiation from sunlight and tanning beds. Melanoma’s initial symptoms involve changes in an existing mole and the development of a new pigment or odd-looking skin production.
More studies may shed more light on the positive association between poultry consumption and prostate cancer and lymphoma of non-Hodgkin, the researchers said.
The consumption of poultry was positively associated with the risk of malignant melanoma (HR per 30 g / day rise in intake of 1.20, 95% CI 1.00-1.44), prostate cancer (1.11, 1.02-1.22) and non-Hodgkin lymphoma (1.26, 1.03-1.55),’ A. Kruppel and colleagues wrote in their study.
